M Kroese, D Kanka. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisEmergency Medical Services/economicsHumansMyocardial Infarction/drug therapyThrombolytic Therapy/economics
Year: 2003 PMID: 14593065 PMCID: PMC261709 DOI: 10.1136/bmj.327.7422.1051-a
Source DB: PubMed Journal: BMJ ISSN: 0959-8138